In 19 games this season for the Sixers, Markelle Fultz is averaging 8.2 points, 3.7 rebounds and 3.1 assists while shooting 41.9 percent from the field, 28.6 percent from beyond the arc and 56.8 percent from the free-throw line. The nerve-altering issue is described as a compression or irriation between the lower neck and upper chest, the team announced.
As reported by Adrian Wojnarowski of ESPN Tuesday, Fultz's agent says he's been "diagnosed with Neurogenic Thoracic Outlet Syndrome, (TOS), a physical injury that affects nerves between the neck and shoulders". "TOS is treatable by physical therapy".
The news comes just days after it was revealed that the Sixers would be open to trading the former No. 1 overall pick, who has been limited to just 33 games over the course of his first two seasons due to injuries and shooting struggles.
Fultz, 20, has seen many specialists in the past year, beyond his care with the 76ers' training staff. This latest diagnosis appears to be the result of this evaluation, and is hopefully for Fultz and the 76ers alike a turning point in his career, allowing him to recover from an issue that has plagued him since he first entered the National Basketball Association.
Eskin also added the team has been treating Fultz appropriately for TOS without calling it that.
The condition will be treated with physical therapy. Therefore, severely limiting Fultz's ability to shoot a basketball.